About Shensongyangxin capsule climacteric syndrome by.docVIP

 PAGE \* MERGEFORMAT 6 About Shensongyangxin capsule climacteric syndrome by [Keywords:] Shensongyangxin capsule, perimenopausal syndrome Perimenopausal syndrome refers to the decline of ovarian function in women to the disappearance of the transitional period, due to endocrine disorders caused by autonomic dysfunction, metabolic syndrome, a disorder based, such as menstrual disorders, reheat sweating, dizziness, tinnitus, the red hot flashes, irritability, palpitations, insomnia, abnormal emotions, memory loss, blood pressure fluctuations .2005-2006, the author applied Shensongyangxin capsule treatment of the disease, results were satisfactory, are summarized below. 1 Materials and Methods 1.1 Diagnostic criteria Reference lt;lt;Chinese new drug clinical research guidance Policy “gt; [1] The female climacteric syndrome developed diagnostic criteria. ① aged between 40 and 60 years, ② symptoms of menstrual disorders than outside, with a reheat sweating, hot flashes red face, dizziness, tinnitus, dysphoria fever, irritability, palpitations, insomnia, abnormal emotions, memory loss, blood pressure fluctuations; ③ estradiol (E2) levels decreased, follicle-stimulating EPO (FSH), luteinizing hormone (LH) levels. 1.2 General Information 96 cases were hospital out-patient cases were randomly divided into treatment group and control group. The treatment group, 48 patients aged 40 to 59 years (mean 48.5 + -3.1) years, duration of less than 1 year in 28 cases, 1 5 years in 12 cases, 8 cases of more than 5 years. the control group 48 patients aged 41 to 58 years (mean 8.2 + -3.5) years, duration of less than 1 in 26 cases, 1 to 5 years in 14 cases , greater than 5 years in 8 patients .2 groups in age, illness, disease, etc. There was no significant difference (P lt;0.05), comparable. 1.3 Treatment The treatment group received Shensongyangxin capsule (Shijiazhuang Yiling Pharmaceutical Co., Ltd., Zhunzi: , each 4 pills 3 times a day. Co